These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16856829)

  • 21. Caffeine or theophylline for neonatal apnoea?
    Scanlon JE; Chin KC; Morgan ME; Durbin GM; Hale KA; Brown SS
    Arch Dis Child; 1992 Apr; 67(4 Spec No):425-8. PubMed ID: 1586184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Xanthines in apnea of premature infants. Influence on gastroesophageal reflux].
    Sacré L; Vandenplas Y
    Arch Fr Pediatr; 1987 May; 44(5):383-5. PubMed ID: 3619572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of formula feeding on oral absorption of caffeine in premature infants.
    Giacoia GP; Jungbluth GL; Jusko WJ
    Dev Pharmacol Ther; 1989; 12(4):205-10. PubMed ID: 2766923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of dose and plasma concentrations of caffeine and ventilation in neonatal apnea.
    Turmen T; Davis J; Aranda JV
    Semin Perinatol; 1981 Oct; 5(4):326-31. PubMed ID: 7302607
    [No Abstract]   [Full Text] [Related]  

  • 26. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity.
    Chereches-Panta P; Nanulescu MV; Culea M; Palibroda N
    J Perinatol; 2007 Nov; 27(11):709-12. PubMed ID: 17717520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
    Vatlach S; Arand J; Engel C; Poets CF
    Neonatology; 2014; 105(2):108-11. PubMed ID: 24335098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of 2 different maintenance doses of caffeine in the treatment of apnea in premature infants].
    Autret E; Breteau M; Laugier J; Gold F; Gautier C; Majzoub S
    Therapie; 1985; 40(4):235-9. PubMed ID: 4024019
    [No Abstract]   [Full Text] [Related]  

  • 30. Percutaneous caffeine application in the treatment of neonatal apnoea.
    Amato M; Isenschmid M; Hüppi P
    Eur J Pediatr; 1991 Jun; 150(8):592-4. PubMed ID: 1954966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge.
    Doyle J; Davidson D; Katz S; Varela M; Demeglio D; DeCristofaro J
    J Perinatol; 2016 Feb; 36(2):141-4. PubMed ID: 26562367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life.
    Lönnerholm G; Lindström B; Paalzow L; Sedin G
    Eur J Clin Pharmacol; 1983; 24(3):371-4. PubMed ID: 6861850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periextubation caffeine in preterm neonates: a randomized dose response trial.
    Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
    J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of caffeine in apnea in premature infants].
    Saint-Martin J; Duhamel S; Choulot JJ
    Pediatrie; 1980; 35(1):21-7. PubMed ID: 7367145
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum caffeine concentrations in preterm infants: a retrospective study.
    Sugino M; Kuboi T; Noguchi Y; Nishioka K; Tadatomo Y; Kawaguchi N; Sadamura T; Nakano A; Konishi Y; Koyano K; Nakamura S; Okada H; Itoh S; Kusaka T
    Sci Rep; 2023 Jun; 13(1):10305. PubMed ID: 37365252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, controlled, double-blind trial comparing two loading doses of aminophylline.
    Hochwald C; Kennedy K; Chang J; Moya F
    J Perinatol; 2002 Jun; 22(4):275-8. PubMed ID: 12032788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of caffeine on diaphragmatic activity in preterm infants.
    Dani C; Fusco M; Manti S; Marseglia L; Ciarcià M; Leonardi V; Corsini I; Gitto E
    Pediatr Pulmonol; 2023 Jul; 58(7):2104-2110. PubMed ID: 37144862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
    García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
    Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.